• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Public Health . Post-infection symptoms up to 24 months after COVID-19: a matched cohort study in Berlin, Germany

tetano

Editor, Senior Moderator
Front Public Health


. 2025 Mar 12:13:1513664.
doi: 10.3389/fpubh.2025.1513664. eCollection 2025. Post-infection symptoms up to 24 months after COVID-19: a matched cohort study in Berlin, Germany

Anne Meierkord[SUP] 1 2 [/SUP], Daniel Schulze[SUP] 3 [/SUP], Maximilian Gertler[SUP] 1 [/SUP], Joachim Seybold[SUP] 4 [/SUP], Marcus A Mall[SUP] 5 6 7 [/SUP], Tobias Kurth[SUP] 8 [/SUP], Frank P Mockenhaupt[SUP] #[/SUP][SUP] 1 [/SUP], Stefanie Theuring[SUP] #[/SUP][SUP] 1 [/SUP]



Affiliations
Abstract

Introduction: Long-term health consequences after mild COVID-19 are not well described. Our aim was to estimate their prevalence and describe the time course of signs and symptoms for a period of up to 24 months after SARS-CoV-2 infection.
Methods: We conducted a cohort study matched for age, sex, and test week among individuals who had attended the public COVID-19 test center at Charité-Universitätsmedizin Berlin, Germany. In early 2022, 576 former COVID-19 patients (>95% non-hospitalized) and 302 uninfected individuals responded to a questionnaire on retrospective monthly symptoms since the test date up to 24 months ago.
Results: Symptoms compatible with long COVID were present in 42.9% (247/576) of former COVID-19 patients, compared with 21.2% (64/302) in the uninfected group. In former patients, unadjusted odds ratios (OR) were highest for disturbed taste/smell (OR 9.1 [95% CI: 4.0-21.1]), memory difficulties (OR 5.1 [95% CI: 2.9-8.9]), and shortness of breath at rest (OR 4.5 [95% CI: 1.9-10.6]). In most former COVID-19 patients, symptoms occurred in one coherent period and resolved after a median of 6.5 months, while taste/smell disturbance and neurological/cognitive symptoms showed longer times until recovery. Factors associated with long COVID-compatible symptoms included hospitalization, symptomatic COVID-19 infection, low household income and female sex.
Conclusion: Post-infection symptoms in mild COVID-19 patients mostly persist for about half a year, but sometimes longer. Among uninfected individuals who never experienced COVID-19, 21.2% also reported long COVID-compatible symptoms. The current long COVID definition might require revision to prevent misclassification and over-reporting, and to improve diagnosis and prevalence estimates.

Keywords: COVID-19; SARS-CoV-2; long COVID; post COVID-19 condition; post-acute sequel of COVID-19.

 
Back
Top Bottom